This website uses cookies to improve your experience.

Cookie policy

Transanal versus laparoscopic total mesorectal excision for mid and low rectal cancer (Ta-LaTME study): multicentre, randomized, open-label trial.


Serra-Aracil X, Zarate A, Bargallo J, Gonzalez A, Serracant A, Roura J et al for the Ta-LaTME study Group.

Br J Surg 2023; 110: 150–158.

This study included 105 evaluable patients. Conversion to open surgery was needed after 20 per cent of transanal, versus 2 per cent of laparoscopic procedures, P=0.003. Morbidity rates, and postoperative recovery were similar. After a median of 39 months recurrence rates were similar: 6.1 percent laparoscopic, and 1.8 per cent transanal surgery.

Comment: This is a brave study, but really too small to answer many of the questions that remain about TaTME. Longer term follow-up will be important.

Read paper

Academy


Part of the charitable activity of the Foundation, BJS Academy is an online educational resource for current and future surgeons.

The Academy is comprised of five distinct sections: Continuing surgical education, Young BJS, Cutting edge, Scientific surgery and Surgical news. Although the majority of this is open access, additional content is available to BJS subscribers and strategic partners.

Discover the Academy
Surgeon Training & Surgeons in Surgery